TP53 and breast neoplasm: Compared to those with wild-type TP53 tumors, patients with TP53-mutated breast tumors demonstrate higher levels of immune infiltration and more active immunity, which further indicates better survival outcomes (Guo et al., 2017; Liu et al., 2019).